THE DRUG SAFETY RESEARCH TRUST
Financial health, per its FY2023 accounts
The accounts state that the charity reported a net expenditure of £293,641 for the year, resulting in a decrease in total funds from £8,766,908 to £8,473,267. The trustees confirm that the charity maintains sufficient free reserves to continue as a going concern for at least two years in the event of a significant drop in income. Staff costs remained the highest expenditure at £1,498,506, while total incoming resources were £2,688,576.
What the accounts disclose
“It is the policy of the charity to maintain unrestricted funds, which are the free reserves of the charity. This provides sufficient funds to cover the cost of ongoing studies, management and administration costs. Considering expected fluctuations of future income, the financial reserves are necessary to maintain the future stability and viability of the DSRU.” — page 10
Structured financials (annual return, FY ending 31/12/2024)
Trustees
- PROFESSOR KENNETH ROSS PATERSONchair
- PROFESSOR ALAN JOHN CAMM QHP BSC
- PROFESSOR MARTIN PATTERSON VESSEY CBE FRCP
- Professor Allan Hunter Young
- Professor Isla Shelagh Mackenzie MBChB
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £1.2m | £2.5m |
| 31/12/2023 | £2.3m | £2.7m |
| 31/12/2022 | £1.9m | £2.7m |
| 31/12/2021 | £4.0m | £2.8m |
| 31/12/2020 | £1.4m | £1.6m |
Common questions
Is THE DRUG SAFETY RESEARCH TRUST financially healthy?
The accounts state that the charity reported a net expenditure of £293,641 for the year, resulting in a decrease in total funds from £8,766,908 to £8,473,267. The trustees confirm that the charity maintains sufficient free reserves to continue as a going concern for at least two years in the event of a significant drop in income. Staff costs remained the highest expenditure at £1,498,506, while total incoming resources were £2,688,576. Its FY2023 accounts were audited by Cartwrights.